KarpatiG.Myoblast transfer in Duchenne muscular dystrophy.Ann Neurol.34: 8–17; 1993.
5.
LawP.K.Cell transplantation as an experimental treatment for Duchenne muscular dystrophy.Cell Transplantation2: 485–505; 1993.
6.
MendellJ.R.Myoblast transfer in the treatment of Duchenne's muscular dystrophy.New Eng. J. Med.333: 832–8; 1995.
7.
MorandiL.Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer.Neuromusc. Dis.5: 291–295; 1995.
8.
TremblayJ.P.Results of a triple blind study of myoblast transplantation without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.Cell Transplantation2: 99–112; 1993.
9.
WernigA. and IrintchevA.“Bystander” damage of host muscle caused by implantation of MHC-compatible myogenic cells.J. Neurol. Sci.130: 190–196; 1995.
10.
PartridgeT.A.Animal models of muscular dystrophy - What can they teach us? Neuropathol.Appl. Neurobiol17: 353–63; 1991.
11.
PartridgeT.A.Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts.Nature337: 176–179; 1989.
12.
KinoshitaI.Very efficient myoblast transfer in mice under FK506 immunosuppression.Muscle Nerve17: 1407–1415; 1994.
13.
KinoshitaI.Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficiacy of their transplantation in mdx mice.Muscle Nerve18: 834–841; 1995.
14.
FanY.A potential alternative strategy for Myoblast Transfer Therapy: the use of sliced muscle grafts.Cell Transplantation.5: 421–429; 1996.
